Literature DB >> 1650459

Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells.

B S Chapman1, R M Thayer, K A Vincent, N L Haigwood.   

Abstract

A 2.4 kb fragment of hCMV (Towne strain), containing the 5' end of the major immediate-early gene, has been cloned, sequenced, and used to construct a series of mammalian cell expression plasmids. The effects of regulatory regions present on this fragment were assessed using human glycoproteins as reporter molecules. We compared secreted levels of Factor VIII, t-PA, and HIV-1 envelope glycoproteins in cells transfected with plasmids in which intron A of the immediate-early gene was present or absent. Secretion of several glycoproteins was significantly higher when cells were transfected with intron A-containing plasmids. Mutation of three basepairs in the strong nuclear factor 1 (NF1) binding site in intron A led to reduced transient expression levels, but not to the level observed in the absence of intron A. Reduced expression from NF1 mutant plasmids was roughly correlated with reduced binding in vitro of NF1 proteins to a synthetic oligonucleotide containing the mutation. The evidence indicates that sequences in intron A positively regulate expression from the hCMV immediate-early enhancer/promoter in transformed monkey kidney cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1650459      PMCID: PMC328492          DOI: 10.1093/nar/19.14.3979

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  47 in total

1.  Negative and positive regulation by a short segment in the 5'-flanking region of the human cytomegalovirus major immediate-early gene.

Authors:  J A Nelson; C Reynolds-Kohler; B A Smith
Journal:  Mol Cell Biol       Date:  1987-11       Impact factor: 4.272

2.  Cell-specific activity of the modulator region in the human cytomegalovirus major immediate-early gene.

Authors:  H Lubon; P Ghazal; L Hennighausen; C Reynolds-Kohler; C Lockshin; J Nelson
Journal:  Mol Cell Biol       Date:  1989-03       Impact factor: 4.272

3.  Negative regulation of viral enhancers in undifferentiated embryonic stem cells.

Authors:  C M Gorman; P W Rigby; D P Lane
Journal:  Cell       Date:  1985-09       Impact factor: 41.582

4.  An internal regulatory element controls troponin I gene expression.

Authors:  K E Yutzey; R L Kline; S F Konieczny
Journal:  Mol Cell Biol       Date:  1989-04       Impact factor: 4.272

5.  Importance of introns for expression of mouse ribosomal protein gene rpL32.

Authors:  S Chung; R P Perry
Journal:  Mol Cell Biol       Date:  1989-05       Impact factor: 4.272

6.  Patterns of polyadenylation site selection in gene constructs containing multiple polyadenylation signals.

Authors:  R M Denome; C N Cole
Journal:  Mol Cell Biol       Date:  1988-11       Impact factor: 4.272

7.  Cell-specific processing of preprosomatostatin in cultured neuroendocrine cells.

Authors:  K A Sevarino; R Felix; C M Banks; M J Low; M R Montminy; G Mandel; R H Goodman
Journal:  J Biol Chem       Date:  1987-04-15       Impact factor: 5.157

8.  Construction and characterization of an active factor VIII variant lacking the central one-third of the molecule.

Authors:  D L Eaton; W I Wood; D Eaton; P E Hass; P Hollingshead; K Wion; J Mather; R M Lawn; G A Vehar; C Gorman
Journal:  Biochemistry       Date:  1986-12-30       Impact factor: 3.162

9.  Growth hormone gene expression in eukaryotic cells directed by the Rous sarcoma virus long terminal repeat or cytomegalovirus immediate-early promoter.

Authors:  F Pasleau; M J Tocci; F Leung; J J Kopchick
Journal:  Gene       Date:  1985       Impact factor: 3.688

10.  Regulatory elements in the 5'-flanking region and the first intron contribute to transcriptional control of the mouse alpha 1 type I collagen gene.

Authors:  R A Rippe; S I Lorenzen; D A Brenner; M Breindl
Journal:  Mol Cell Biol       Date:  1989-05       Impact factor: 4.272

View more
  83 in total

1.  DNA vaccination with the human immunodeficiency virus type 1 SF162DeltaV2 envelope elicits immune responses that offer partial protection from simian/human immunodeficiency virus infection to CD8(+) T-cell-depleted rhesus macaques.

Authors:  S Cherpelis; I Shrivastava; A Gettie; X Jin; D D Ho; S W Barnett; L Stamatatos
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

2.  The ability of an oligomeric human immunodeficiency virus type 1 (HIV-1) envelope antigen to elicit neutralizing antibodies against primary HIV-1 isolates is improved following partial deletion of the second hypervariable region.

Authors:  S W Barnett; S Lu; I Srivastava; S Cherpelis; A Gettie; J Blanchard; S Wang; I Mboudjeka; L Leung; Y Lian; A Fong; C Buckner; A Ly; S Hilt; J Ulmer; C T Wild; J R Mascola; L Stamatatos
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

3.  Changes in the immunogenic properties of soluble gp140 human immunodeficiency virus envelope constructs upon partial deletion of the second hypervariable region.

Authors:  Indresh K Srivastava; Keating VanDorsten; Lucia Vojtech; Susan W Barnett; Leonidas Stamatatos
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

4.  Comparative analysis of immune responses induced by vaccination with SIV antigens by recombinant Ad5 vector or plasmid DNA in rhesus macaques.

Authors:  Lauren A Hirao; Ling Wu; Abhishek Satishchandran; Amir S Khan; Ruxandra Draghia-Akli; Adam C Finnefrock; Andrew J Bett; Michael R Betts; Danilo R Casimiro; Niranjan Y Sardesai; J Joseph Kim; John W Shiver; David B Weiner
Journal:  Mol Ther       Date:  2010-06-15       Impact factor: 11.454

5.  Identification of highest-affinity ligands by affinity selection from equimolar peptide mixtures generated by robotic synthesis.

Authors:  R N Zuckermann; J M Kerr; M A Siani; S C Banville; D V Santi
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

Review 6.  Plasmid DNA vaccine vector design: impact on efficacy, safety and upstream production.

Authors:  James A Williams; Aaron E Carnes; Clague P Hodgson
Journal:  Biotechnol Adv       Date:  2009-02-20       Impact factor: 14.227

7.  Purification, characterization, and immunogenicity of a soluble trimeric envelope protein containing a partial deletion of the V2 loop derived from SF162, an R5-tropic human immunodeficiency virus type 1 isolate.

Authors:  Indresh K Srivastava; Leonidas Stamatatos; Elaine Kan; Michael Vajdy; Ying Lian; Susan Hilt; Loic Martin; Claudio Vita; Ping Zhu; Kenneth H Roux; Lucia Vojtech; David C Montefiori; John Donnelly; Jeffrey B Ulmer; Susan W Barnett
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

8.  Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation.

Authors:  C D Gimmi; G J Freeman; J G Gribben; G Gray; L M Nadler
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

9.  Comparative immunogenicity of subtype a Human Immunodeficiency Virus type 1 envelope exhibiting differential exposure of conserved neutralization epitopes.

Authors:  Catherine A Blish; D Noah Sather; George Sellhorn; Leonidas Stamatatos; Yide Sun; Indresh Srivastava; Susan W Barnett; Brad Cleveland; Julie Overbaugh; Shiu-lok Hu
Journal:  J Virol       Date:  2009-12-16       Impact factor: 5.103

10.  Lipid-mediated delivery of RNA is more efficient than delivery of DNA in non-dividing cells.

Authors:  S Zou; K Scarfo; M H Nantz; J G Hecker
Journal:  Int J Pharm       Date:  2010-01-18       Impact factor: 5.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.